TABLE 2.
PBP2 variant | MIC (mg/liter)a |
|||
---|---|---|---|---|
Cefixime | Ceftriaxone | Ertapenem | Meropenem | |
Wild type | 0.0023 ± 0.0015 | 0.0005 ± 0 | 0.016 ± 0 | 0.016 ± 0 |
Nonmosaic I | 0.008 ± 0 | 0.004 ± 0 | 0.0267 ± 0.0092 | 0.016 ± 0 |
Nonmosaic I H168Y | 0.0053 ± 0.0023 | 0.0033 ± 0.0012 | 0.0267 ± 0.0092 | 0.016 ± 0 |
Nonmosaic II | 0.0067 ± 0.0023 | 0.0033 ± 0.0012 | 0.0267 ± 0.0092 | 0.016 ± 0 |
Nonmosaic II A501V | 0.0213 ± 0.0092 | 0.008 ± 0 | 0.0267 ± 0.0092 | 0.016 ± 0 |
Nonmosaic II V78I | 0.0067 ± 0.0023 | 0.004 ± 0 | 0.0267 ± 0.0092 | 0.016 ± 0 |
Nonmosaic_IV | 0.008 ± 0 | 0.004 ± 0 | 0.0267 ± 0.0092 | 0.016 ± 0 |
Nonmosaic_V | 0.008 ± 0 | 0.004 ± 0 | 0.032 ± 0 | 0.016 ± 0 |
Nonmosaic V MNP* | 0.008 ± 0 | 0.004 ± 0 | 0.0213 ± 0.0092 | 0.016 ± 0 |
Nonmosaic IX | 0.008 ± 0 | 0.004 ± 0 | 0.032 ± 0 | 0.0213 ± 0.0092 |
Nonmosaic XII | 0.0107 ± 0.0046 | 0.0053 ± 0.0023 | 0.032 ± 0 | 0.0213 ± 0.0092 |
Nonmosaic XIII | 0.032 ± 0 | 0.008 ± 0 | 0.032 ± 0 | 0.016 ± 0 |
Nonmosaic XXII | 0.004 ± 0 | 0.0027 ± 0.0012 | 0.0213 ± 0.0092 | 0.016 ± 0 |
Mosaic X | 0.125 ± 0 | 0.0107 ± 0.0046 | 0.125 ± 0 | 0.125 ± 0 |
Mosaic XXXIV | 0.0637 ± 0.0006 | 0.008 ± 0 | 0.125 ± 0 | 0.0843 ± 0.0352 |
Mosaic XXXIV E538G | 0.0637 ± 0.0006 | 0.008 ± 0 | 0.1047 ± 0.0352 | 0.0843 ± 0.0352 |
Mosaic XXXIV A501P | 1 ± 0 | 0.25 ± 0 | 0.016 ± 0 | 0.016 ± 0 |
ATCC 49226 | 0.0267 ± 0.0092 | 0.0133 ± 0.0046 | 0.125 ± 0 | 0.1047 ± 0.0352 |
WHO F | 0.0033 ± 0.0012 | 0.001 ± 0 | 0.016 ± 0 | 0.0133 ± 0.0046 |
F89 | ≥4 ± 0 | 2 ± 0 | 0.1047 ± 0.0352 | 0.1047 ± 0.0352 |
MICs were measured in triplicate by the agar dilution method and averages ± SD are shown.